2 days Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $314.00 at Bank of AmericaMarketBeat
Bank of America increased their price target on Alnylam Pharmaceuticals from $307.00 to $314.00 and gave the company a “buy” rating in a research note on Monday.
Bank of America (BAC) · Nasdaq 100 · Pharmaceuticals · Science
X